Работы, цитирующие эту работу

Работ: 5

Работа: High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Обзорная статьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2017Цитирований: 4

   ABIABI:AkademIndex/openalex/2017.review-article.000004

2. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   СтатьяTuberculosis Research and EpidemiologyBMC Medicine2016Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.195695

3. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2019.article.000020

4. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   СтатьяTuberculosis Research and EpidemiologyERJ Open Research2020Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.360284

5. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   СтатьяTuberculosis Research and EpidemiologyPLoS ONE2020Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.360285